N4 Pharma (LON:N4P) Trading 30.1% Higher – Still a Buy?

Shares of N4 Pharma Plc (LON:N4P) rose 30.1% during mid-day trading on Wednesday . The stock traded as high as GBX 0.75 ($0.01) and last traded at GBX 0.68 ($0.01). Approximately 8,268,096 shares changed hands during mid-day trading, an increase of 315% from the average daily volume of 1,994,112 shares. The stock had previously closed at GBX 0.53 ($0.01).

N4 Pharma Stock Up 8.3 %

The stock has a market cap of £2.57 million, a PE ratio of -55.00 and a beta of -0.37. The business has a 50 day moving average price of GBX 0.62 and a 200 day moving average price of GBX 0.57. The company has a quick ratio of 7.28, a current ratio of 22.73 and a debt-to-equity ratio of 1.62.

N4 Pharma Company Profile

N4 Pharma is a specialist pharmaceutical company developing novel delivery systems for oncology, gene therapy and vaccines It has a unique silica nanoparticle delivery system called Nuvec® and another unique peptide.lipid system called Liptide® which it operates through its subsidiary Nanogenics Ltd

N4 Pharma’s business model is to partner with companies developing novel antigens in these fields to use Nuvec® as the delivery vehicle for these antigens.